(19)
(11) EP 2 619 195 A1

(12)

(43) Date of publication:
31.07.2013 Bulletin 2013/31

(21) Application number: 10761101.4

(22) Date of filing: 24.09.2010
(51) International Patent Classification (IPC): 
C07D 403/14(2006.01)
A61K 31/4178(2006.01)
(86) International application number:
PCT/US2010/050138
(87) International publication number:
WO 2012/039717 (29.03.2012 Gazette 2012/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 05843-4000 (US)

(72) Inventors:
  • BELEMA, Makonen
    Wallingford, CT 06492 (US)
  • HEWAWASAM, Piyasena
    Wallingford Connecticut 06492 (US)

(74) Representative: Reitstötter - Kinzebach 
Patentanwälte Sternwartstrasse 4
81679 München
81679 München (DE)

   


(54) HEPATITIS C VIRUS INHIBITORS